Natural killer (NK) cells in chronic progressive multiple sclerosis patients treated with lymphoblastoid interferon
- 1 November 1988
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 20 (1) , 15-23
- https://doi.org/10.1016/0165-5728(88)90109-9
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-α2Clinical Immunology and Immunopathology, 1985
- Multiple SclerosisNew England Journal of Medicine, 1982
- Multiple SclerosisNew England Journal of Medicine, 1982
- Lack of correlation between impaired Interferon production and natural killer activity of lymphocytes in multiple sclerosisArchiv für die gesamte Virusforschung, 1982
- PPD‐, PWM‐, and PHA‐induced interferon in stable multiple sclerosis: Association with HLA‐DW2 antigen and clinical variablesAnnals of Neurology, 1982
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981
- Interferon‐Induced NK Augmentation in HumansScandinavian Journal of Immunology, 1981
- The significance of abnormal immune responses in patients with multiple sclerosisJournal of Neuroimmunology, 1981
- Interferons and the immune systemNature, 1980
- PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965